CASI Pharmaceuticals Inc · CASI.US · Annual · 2024-12-31 · compared with 2023-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $53.67M − (Liabilities $51.82M + Equity $1.85M) = $0.00 · in balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$13.47M
25.1%
-$3.62M
-21.2%
Assets
Receivables
$15.35M
28.6%
$5.21M
51.4%
Assets
Inventory
$5.25M
9.8%
-$10.63M
-66.9%
Assets
Other current assets
$2.89M
5.4%
$328.00K
12.8%
Assets
PPE
$11.36M
21.2%
-$273.00K
-2.3%
Assets
Investments
$1.72M
3.2%
$35.00K
2.1%
Assets
Other
$3.65M
6.8%
-$12.65M
-77.6%
Liabilities + Equity
Accounts payable
$2.72M
5.1%
-$1.72M
-38.6%
Liabilities + Equity
Short-term debt
$19.61M
36.5%
$18.88M
2,593.1%
Liabilities + Equity
Other liabilities
$29.49M
55.0%
-$16.44M
-35.8%
Liabilities + Equity
Equity
$1.85M
3.4%
-$22.31M
-92.3%